Category : Healthcare Quality, Patient Safety & Policy

The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to...

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, today announced that it has submitted a 510(k) premarket...

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study evaluating the efficacy and safety of upadacitinib (RINVOQ®) 15 mg, once...

New U.S. data will offer first-of-its-kind evidence in patients with kidney failure  DaVita today announced the launch of two groundbreaking initiatives aimed to deepen the medical...

Healthfirst, a leading not-for-profit health plan serving more than two million New Yorkers, today announced the winners of its inaugural Pharmacy Excellence Awards, recognizing 12...

Achievement Follows Healthfirst’s #1 Quality Rating Among New York State Medicaid and Essential Plans Healthfirst, a leading not-for-profit health plan serving more than two million...

Launch of new healthcare plan for dual-eligible members of Medi-Cal and Medicare Enrollment begins October 15 This week CenCal Health announced the launch of CenCal CareConnect, a new...

Aetna®, a CVS Health® company (NYSE: CVS), announced today that over 81 percent of its Medicare Advantage (MA) members are in 2026 Medicare Advantage Prescription Drug...

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; “Renalys”) announced today that it has completed data collection for the primary endpoint in the Phase III clinical trial...

Kiel Laboratories, a leading strategic consulting and pharmaceutical services provider, announced the successful approval of its 16th New Drug Application (NDA) through the U.S. Food...

Millennium Physician Group, one of the largest physician-led healthcare groups in Florida, and IMA Medical Group, one of the largest Central Florida-based provider groups, announced...

Acquisition Expands National Patient Base and Strengthens Aptiva’s Leadership in Continuous Glucose Monitoring (CGM) Distribution Aptiva Medical, a Greenleaf Ventures portfolio company and one of...

Kronos, once valued at $3.5B, Had Two Phase 2 Stage Assets Ignota Labs, the AI drug turnaround company, has announced its acquisition of Kronos’s clinical...

Former Oracle leader joins to advance launch intelligence innovation Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon,...